Literature DB >> 25337184

Triggering the succinate receptor GPR91 enhances pressure overload-induced right ventricular hypertrophy.

Lei Yang1, Di Yu1, Huan-Huan Fan2, Yu Feng1, Liang Hu1, Wei-Yan Zhang1, Kai Zhou1, Xu-Ming Mo1.   

Abstract

BACKGROUND: Pulmonary arterial hypertension (PAH) leads to pressure overload in the right ventricle (RV) and induces right ventricular hypertrophy (RVH). GPR91 is an orphan G-protein-coupled receptor (GPCR) that has been characterized as a receptor for succinate, which increases in RVH; however, its role remains unknown. METHODS AND
RESULTS: We studied succinate-GPR91 signaling in a pulmonary arterial banding (PAB) model of RVH in the SD rats due to pressure overload. We report that GPR91 was located in cardiomyocytes. We found that the expressions of GPR91 and p-Akt in the RV significantly increased in the PAB model compared with the sham. In the PAB rats, the treatment of succinate further increased the p-Akt levels and aggravated RVH in vivo. In in vitro studies, succinate stimulated the up-regulation of the hypertrophic gene marker anp. All these effects were inhibited by the antagonist of PI3K, wortmannin, both in vivo and in vitro. Finally, we found that the GPR91-PI3K/Akt axis was also up-regulated compared with the sham in human RVH.
CONCLUSIONS: Our results suggest that succinate-GPR91 is involved in RVH via PI3K/Akt signaling in vivo and in vitro. GPR91 may be a novel therapeutic target for RVH induced by pressure overload.

Entities:  

Keywords:  PI3K/Akt; Succinate G-protein-receptor 91; right ventricular hypertrophy

Mesh:

Substances:

Year:  2014        PMID: 25337184      PMCID: PMC4203155     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  49 in total

1.  Cytosolic dynamics of annexin A6 trigger feedback regulation of hypertrophy via atrial natriuretic peptide in cardiomyocytes.

Authors:  Priyam Banerjee; Arun Bandyopadhyay
Journal:  J Biol Chem       Date:  2014-01-08       Impact factor: 5.157

2.  Cardiac characterization of 16 patients with large NF1 gene deletions.

Authors:  R Nguyen; T S Mir; L Kluwe; K Jett; M Kentsch; G Mueller; H Kehrer-Sawatzki; J M Friedman; V-F Mautner
Journal:  Clin Genet       Date:  2012-12-28       Impact factor: 4.438

3.  Succinate modulates Ca(2+) transient and cardiomyocyte viability through PKA-dependent pathway.

Authors:  Carla J Aguiar; Vanessa L Andrade; Enéas R M Gomes; Márcia N M Alves; Marina S Ladeira; Ana Cristina N Pinheiro; Dawidson A Gomes; Alvair P Almeida; Alfredo M Goes; Rodrigo R Resende; Silvia Guatimosim; M Fatima Leite
Journal:  Cell Calcium       Date:  2009-12-16       Impact factor: 6.817

4.  Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors.

Authors:  Weihai He; Frederick J-P Miao; Daniel C-H Lin; Ralf T Schwandner; Zhulun Wang; Jinhai Gao; Jin-Long Chen; Hui Tian; Lei Ling
Journal:  Nature       Date:  2004-05-13       Impact factor: 49.962

5.  Angiotensin II-converting enzyme inhibition improves survival, ventricular remodeling, and myocardial energetics in experimental aortic regurgitation.

Authors:  Marie Arsenault; Adnane Zendaoui; Elise Roussel; Marie-Claude Drolet; Wahiba Dhahri; Audrey Grenier; Suzanne Gascon; Otman Sarrhini; Jacques A Rousseau; Roger Lecomte; Jacques Couet
Journal:  Circ Heart Fail       Date:  2013-07-16       Impact factor: 8.790

6.  Original rat model of high kinetic unilateral pulmonary hypertension surgically induced by combined surgery.

Authors:  Liukun Meng; Xiaoyan Liu; Zhe Zheng; Jun Li; Jian Meng; Yingjie Wei; Shengshou Hu
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02-08       Impact factor: 5.209

7.  A cornerstone of heart failure treatment is not effective in experimental right ventricular failure.

Authors:  Marinus A Borgdorff; Beatrijs Bartelds; Michael G Dickinson; Paul Steendijk; Rolf M F Berger
Journal:  Int J Cardiol       Date:  2013-09-07       Impact factor: 4.164

Review 8.  Right ventricular failure and pathobiology in patients with congenital heart disease - implications for long-term follow-up.

Authors:  Doreen Köhler; Raoul Arnold; Tsvetomir Loukanov; Matthias Gorenflo
Journal:  Front Pediatr       Date:  2013-11-19       Impact factor: 3.418

9.  GPCR-like signaling mediated by smoothened contributes to acquired chemoresistance through activating Gli.

Authors:  Xia Zhan; Juan Wang; Yuan Liu; Yuanqiu Peng; Wenfu Tan
Journal:  Mol Cancer       Date:  2014-01-07       Impact factor: 27.401

10.  Biventricular remodeling in murine models of right ventricular pressure overload.

Authors:  Navin K Kapur; Vikram Paruchuri; Mark J Aronovitz; Xiaoying Qiao; Emily E Mackey; Gerard H Daly; Kishan Ughreja; Jonathan Levine; Robert Blanton; Nicholas S Hill; Richard H Karas
Journal:  PLoS One       Date:  2013-07-30       Impact factor: 3.240

View more
  10 in total

Review 1.  Metabolism in cardiomyopathy: every substrate matters.

Authors:  Julia Ritterhoff; Rong Tian
Journal:  Cardiovasc Res       Date:  2017-03-15       Impact factor: 10.787

2.  The Roles of Mitochondrial Damage-Associated Molecular Patterns in Diseases.

Authors:  Kiichi Nakahira; Shu Hisata; Augustine M K Choi
Journal:  Antioxid Redox Signal       Date:  2015-08-17       Impact factor: 8.401

3.  Glutamine metabolism drives succinate accumulation in plasma and the lung during hemorrhagic shock.

Authors:  Anne L Slaughter; Angelo D'Alessandro; Ernest E Moore; Anirban Banerjee; Christopher C Silliman; Kirk C Hansen; Julie A Reisz; Miguel Fragoso; Matthew J Wither; Anthony W Bacon; Hunter B Moore; Erik D Peltz
Journal:  J Trauma Acute Care Surg       Date:  2016-12       Impact factor: 3.313

4.  Succinate causes pathological cardiomyocyte hypertrophy through GPR91 activation.

Authors:  Carla J Aguiar; João A Rocha-Franco; Pedro A Sousa; Anderson K Santos; Marina Ladeira; Cibele Rocha-Resende; Luiz O Ladeira; Rodrigo R Resende; Fernando A Botoni; Marcos Barrouin Melo; Cristiano X Lima; José M Carballido; Thiago M Cunha; Gustavo B Menezes; Silvia Guatimosim; M Fatima Leite
Journal:  Cell Commun Signal       Date:  2014-12-24       Impact factor: 5.712

5.  Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation.

Authors:  Xianmin Mu; Ting Zhao; Che Xu; Wei Shi; Biao Geng; Jiajia Shen; Chen Zhang; Jinshun Pan; Jing Yang; Shi Hu; Yuanfang Lv; Hao Wen; Qiang You
Journal:  Oncotarget       Date:  2017-02-21

Review 6.  Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases.

Authors:  Serge Grazioli; Jérôme Pugin
Journal:  Front Immunol       Date:  2018-05-04       Impact factor: 7.561

Review 7.  Cardioprotection in right heart failure.

Authors:  Kerstin Boengler; Klaus-Dieter Schlüter; Ralph Theo Schermuly; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2020-03-09       Impact factor: 8.739

8.  Mitochondrial Damage-associated Molecular Patterns as Potential Biomarkers in DCD Heart Transplantation: Lessons From Myocardial Infarction and Cardiac Arrest.

Authors:  Sarah L Longnus; Nina Rutishauser; Mark N Gillespie; Tobias Reichlin; Thierry P Carrel; Maria N Sanz
Journal:  Transplant Direct       Date:  2021-12-16

9.  GPR91 deficiency exacerbates allergic contact dermatitis while reducing arthritic disease in mice.

Authors:  T Rubić-Schneider; N Carballido-Perrig; C Regairaz; L Raad; S Jost; C Rauld; B Christen; G Wieczorek; R Kreutzer; J Dawson; G Lametschwandner; A Littlewood-Evans; J M Carballido
Journal:  Allergy       Date:  2016-09-12       Impact factor: 13.146

10.  GPR91 Receptor Mediates Protection against Doxorubicin-Induced Cardiotoxicity without Altering Its Anticancer Efficacy. An In Vitro Study on H9C2 Cardiomyoblasts and Breast Cancer-Derived MCF-7 Cells.

Authors:  Matthieu Dallons; Esma Alpan; Corentin Schepkens; Vanessa Tagliatti; Jean-Marie Colet
Journal:  Cells       Date:  2020-09-27       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.